# Frontier AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/frontier-ai

- Industry: Software
- Headquarters: London, UK
- Website: www.frontierhealth.ai
- Total disclosed funding: $17M
- Latest round: Seed (Apr 1, 2026)
- Investors on record: 6

## About

Frontier AI Ltd, d.b.a. Frontier Health founded in 2024 by CEO Rachel Finegold in London, UK, develops Juno, an AI-powered solution aimed at enhancing healthcare administration. The company raised GBP 12.37 million in Seed funding on April 1, 2026, led by Atomico, with participation from Firstminute Capital, Tenacity Capital, XYZ Ventures, Avenir and MMC Ventures. The seed round of funding values Frontier Health at GBP 49.59 million post-money.

Frontier Health's primary product, Juno, is an AI-driven solution designed specifically for healthcare administration teams. Juno automates repetitive and high-volume administrative tasks across existing healthcare systems, allowing staff to enhance efficiency and focus on patient care. The platform integrates seamlessly with electronic patient records (EPR), patient administration systems (PAS), and other healthcare frameworks, enabling it to manage complex workflows without requiring a complete system overhaul. Juno addresses prevalent issues in patient care, such as delays in communication, missed follow-ups, and inefficient tracking of patient pathways. Its end users primarily include healthcare administrative teams, operational leaders, and transformation managers within the healthcare sector, particularly in the UK, where it has been deployed successfully in various NHS environments.

Frontier Health generates revenue through partnerships with healthcare organizations, utilizing a subscription-based model where clients pay for access to Juno's suite of administrative solutions. This structure reflects a B2B transaction model, where healthcare trusts and organizations subscribe to the service to automate their administrative tasks and improve operational efficiencies. The pricing plans are structured around the scale of implementation and the specific needs of the client, with different tiers corresponding to the complexity and volume of tasks automated by Juno. By integrating Juno into their administrative processes, clients can expect to see reductions in patient wait times and scheduling inefficiencies, ultimately leading to improved patient outcomes and operational performance.

In April 2026, Frontier Health raised GBP 12.37 million in Seed funding led by Atomico with participation from Firstminute Capital, Tenacity Capital, XYZ Ventures, Avenir and MMC Ventures, which may be used to deepen technical capabilities and grow the Frontier Health team.

## Funding rounds

- Seed, Apr 1, 2026, $17M — MMC Ventures, Atomico, XYZ Ventures, Firstminute Capital, Avenir, Tenacity Capital

## Investors

- MMC Ventures (https://capitalatlas.ai/funds/mmc-ventures) — Seed
- Atomico (https://capitalatlas.ai/funds/atomico) — Seed
- XYZ Ventures (https://capitalatlas.ai/funds/xyz-ventures) — Seed
- Firstminute Capital (https://capitalatlas.ai/funds/firstminute-capital) — Seed
- Avenir — Seed
- Tenacity Capital (https://capitalatlas.ai/funds/tenacity-capital) — Seed